CLINICAL_TRIALS
trial_result
· 2011-02-25
Clinical Trial Update: A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) [Phase 2]
Summary
Phase 2 study of Bevacizumab in previously untreated extensive-stage small cell lung cancer completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-02-25